Aratana Therapeutics to Present at Bank of America Merrill Lynch Animal Health Summit

KANSAS CITY, Kan., Dec. 15, 2015 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals, will present at the Bank of America Merrill Lynch 2015 Animal Health Summit tomorrow in Boston at 8 a.m. ET.

A live webcast will be provided from the event. Interested parties may also access the webcast and view presentation slides for up to 90 days after the event in the Aratana Investor Room.

About Aratana Therapeutics
Aratana Therapeutics is a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for companion animals. Aratana believes that it can leverage the investment in the human biopharmaceutical industry to bring therapeutics to pets in a capital and time efficient manner. The company's pipeline includes therapeutic candidates targeting pain, inappetence, cancer, viral diseases, allergy and other serious medical conditions. Aratana believes the development and commercialization of these therapeutics will permit veterinarians and pet owners to manage pets' medical needs safely and effectively, resulting in longer and improved quality of life for pets. For more information, please visit www.aratana.com.

Contacts
For investor inquires:
Aratana Therapeutics, Inc.
Craig Tooman
[email protected]; (913) 353-1026

For media inquiries:
Tiberend Strategic Advisors, Inc.
Andrew Mielach
[email protected]; (212) 375-2694

SOURCE Aratana Therapeutics, Inc.

Related Links

http://www.aratana.com